解码与NF-κB通路相关的循环RNAs在致癌过程中的功能性作用
Wei Wang1, Kang Zheng1, Zhi Feng2
1Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, 421001, Hunan, China.
Discover oncology
|September 25, 2025
概括
循环RNAs (circRNAs) 是癌症NF-κB通路的关键调节者. 本综述详细介绍了circRNAs如何影响癌症过程及其作为生物标志物和治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 循环RNA (circRNAs) 是非编码RNA,在基因调节中起着至关重要的作用.
- 核因子kappa B (NF-κB) 信号通路是参与癌症发展的细胞过程的关键调节者.
- 新出现的证据突出显示,circRNAs在致癌过程中参与调节NF-κB途径.
研究的目的:
- 审查目前对癌症NF-κB信号通路的circRNA调节的理解.
- 探索circRNAs调节NF-κB活动的功能机制.
- 讨论circRNAs作为生物标志物和各种癌症类型的治疗点的临床相关性.
主要方法:
- 对近期关于circRNAs和癌症NF-κB通路的研究进行文献综述.
- 分析circRNA功能,包括miRNA海绵,蛋白相互作用和翻译.
- 对circRNA表达与临床病理特征和患者结果的相关性分析.
主要成果:
- 循环RNAs充当NF-κB途径的关键调节者,影响癌症特征,如增殖,入侵,亡和免疫逃逸.
- 功能机制包括miRNA海绵化,直接蛋白质结合和转化为,所有这些都汇聚在NF-κB活性上.
- 与NF-κB相关的circRNAs的表达水平与瘤阶段,转移和患者存活率相关.
结论:
- 环RNA/NF-κB轴是癌症生物学中的重要参与者,影响多种瘤过程.
- 与NF-κB相关的circRNAs显示出作为癌症的诊断和预后生物标志物的潜力.
- 针对参与NF-κB信号传递的circRNAs,为新型癌症疗法提供了一个有希望的途径.
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K


